Zarema Gunnels

Zarema E. Gunnels, Ph.D. is an associate in the Washington, D.C., office and member of the Intellectual Property Practice Group’s Patent Team.
Zarema procures patents and assists with IP portfolio development and strategy in the areas of immunology, enzymes (particularly those useful in biofuel and industrial-enzyme applications), genetics and nucleotides, protein and peptide chemistry, pharmaceuticals, and microbiology.  She also prepares infringement, freedom-to-operate, validity, and due diligence opinions.
Prior to joining Drinker Biddle, Zarema was an associate at a large intellectual property firm, where she gained extensive experience in patent litigation, prosecution and opinion matters.
In General.  She received her bachelor’s degree in biology, magna cum laude, from the University of Louisville in 1997 and her Ph.D. in physiology and biophysics from the University of Louisville School of Medicine in 2002.  In 2005, she earned her J.D., cum laude, from the University of Georgia School of Law, where she served as a Notes Editor for the Georgia Law Review.
During law school, she served as a governor’s intern for the Hon. Charles A. Pannell, Jr. of the United States District Court for the Northern District of Georgia.
Zarema is fluent in Russian.
Publications First author, “Nitric Oxide Donor Induces Nitration of PKCe, Facilitating PKCe Translocation via Enhanced PKCe-RACK2 Interactions: A Novel Mechanism of NO-Triggered Activation of PKCe,” The Journal of Biological Chemistry 277(17): 15021-15027, 2002.
Co-author, “Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits,” Circulation Research 85:542-550, 1999.
Co-author, “Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: A signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning,” Circulation Research 84: 587-604, 1999.
Speaking Engagements

  • Oral Paper Presentation, American Heart Association 74th Scientific Sessions, Anaheim, CA, 2001
  • Oral Poster Presentation, XII World Congress of the International Society for Heart Research, Winnipeg, Canada, 2001 (Recipient of Best Poster Presentation Award)

 

Admitted in Georgia and the U.S. Patent and Trademark Office.  District of Columbia Bar application pending; practice supervised by partners of the firm who are active D.C. Bar members pursuant to D.C. Bar Rule 49(c)(8).



From the Blog

Privately Held Medical Device and Drug Companies Face Unique Sunshine Act Challenges

As widely reported, the Centers for Medicare and Medicaid Services (“CMS”) recently issued regulations implementing the Sunshine Act provisions of the Affordable Care Act. ...

What Goes Up…Must Come Down: Viagra patent invalidated by Canadian Supreme Court

Pfizer and Teva have been fighting a legal battle over Pfizer’s patent for Viagra in Canada.  The first shot was fired when Novopharm Limited,...

The Perils and Promise of 3D Printing: Are DIY Life Sciences in Your Future?

With news that 3D printing (without question one of the coolest technologies to come down the road in quite some time) can be used...